Create an adaptive risk model annex document for AI-driven drug discovery projects addressing evolving FDA guidance on machine learning in pharmaceutical development

Generate create an adaptive risk model annex document for ai-driven drug discovery projects addressing evolving fda guidance on machine learning in pharmaceutical development for Scientific Research and Development Services industry

Scientific Research and Development Services

Agent Configuration

Login required: You need to sign in to execute this agent.

Click to upload or drag and drop

Allowed: PDF, DOCX, TXT

Max size: 50MB

Upload the latest FDA guidance documents (draft or final) on AI/ML in drug development, including relevant Federal Register notices and public comments
Specify the current development stage to address appropriate regulatory expectations
Identify the FDA division(s) that will primarily review this AI application
Categorize the risk level based on AI model impact on patient safety and decision-making
List the primary data sources and databases utilized for model training and validation
Specify the anticipated submission pathway requiring AI model documentation
Define the level of explainability required by FDA based on model complexity
Indicate relevant quality standards governing AI development in your organization
Define the specific validation approaches and statistical methods for regulatory acceptance
Reference FDA-approved AI applications similar to your use case for regulatory precedent
Indicate the timeline flexibility for FDA review and feedback cycles